The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Peripheral Arterial Disease Global Market Report 2023, the peripheral arterial disease market is expected to show promising growth in the forecast period.

The peripheral arterial disease (PAD) market has witnessed robust growth, surging from $4 billion in 2023 to an estimated $4.36 billion in 2024, reflecting an impressive Compound Annual Growth Rate (CAGR) of 9.1%. This momentum is anticipated to continue, with a forecasted market size of $6.05 billion in 2028, driven by an 8.5% CAGR. Let’s delve into the factors catalyzing this growth, explore the anticipated trends, and understand the innovative strategies shaping the future of PAD treatment.

Cardiac Disease Prevalence: A Driving Force for PAD Market Growth

• Rising prevalence of cardiac diseases fuels the growth of the PAD market
• PAD treatments contribute to improved blood flow, cardiovascular risk reduction, and symptom relief
• Cardiovascular disease-related deaths reached 695,547 in 2021, emphasizing the need for effective PAD interventions

Market Players: Pioneers in Innovation and Drug Development

• Key players include Cardinal Health Inc., Johnson & Johnson Limited, Abbott Laboratories, and others
• Focus on innovative drug development initiatives to sustain market leadership
• Example: Janssen Pharmaceutical Companies’ XARELTO receives FDA approval for expanded PAD indication

Strategic Mergers: Abbott Laboratories’ Acquisition of Cardiovascular Systems Inc

• Abbott Laboratories acquires Cardiovascular Systems Inc. for $890 million
• Acquisition strengthens Abbott’s cardiovascular portfolio and introduces complementary technologies
• Cardiovascular Systems Inc. specializes in developing products for treating peripheral and coronary vascular disease

Market Segmentation: Precision in Treatment Approaches

• Treatment Types: Devices, Catheters, Drugs, Other Types
• Route of Administration: Oral, Parenteral, Other Routes of Administrations
• End Users: Hospitals, Specialty Clinics, Other End-Users

Global Dominance: North America Takes the Lead

• North America emerges as the largest region in the peripheral artery disease market in 2023
• The region’s advanced healthcare infrastructure contributes to market dominance

View More On The Peripheral Arterial Disease Market Report 2023 – https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Innovative Drug Development Initiatives: A Pillar of Advancement

• Companies focus on developing innovative drugs to improve PAD treatment outcomes
• Janssen Pharmaceutical Companies’ XARELTO gains expanded FDA indication, offering a comprehensive solution for CAD and PAD
• Ongoing drug development aims to reduce complications and enhance patient outcomes

Strategic Responses to Market Dynamics: Abbott’s Forward-Thinking Approach

• Abbott Laboratories responds proactively to market dynamics with strategic acquisitions
• Acquisition of Cardiovascular Systems Inc. showcases Abbott’s commitment to bolstering its cardiovascular portfolio

Anticipated Trends: Vascular Tele-Rehabilitation and Multimodal Pain Management

• Vascular tele-rehabilitation emerges as a trend in the PAD market
• Multimodal pain management gains prominence for comprehensive patient care
• Advances in wound care and public health campaigns contribute to ongoing trends in the forecast period

Request A Sample Of The Global Peripheral Arterial Disease Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12999&type=smp

The Peripheral Arterial Disease Global Market Report 2023  offers a comprehensive overview on the peripheral arterial disease market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the peripheral arterial disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Peripheral Arterial Disease Market Include:
1. Peripheral Arterial Disease Market Executive Summary
2. Peripheral Arterial Disease Market Segments
3. Peripheral Arterial Disease Market Size And Peripheral Arterial Disease Market Growth Rate
4. Key Peripheral Arterial Disease Market Trends
5. Major Peripheral Arterial Disease Market Drivers
……
25. Key Mergers And Acquisitions In The Peripheral Arterial Disease Market
26. Top Peripheral Arterial Disease Companies
27. Peripheral Arterial Disease Market Opportunities And Strategies
28. Peripheral Arterial Disease Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
Low-Density Lipoprotein Test Global Market Report 2023
Pulmonary Arterial Hypertension Global Market Report 2023
Drug Infusion Systems Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model